Compression Therapy Market (2026 - 2033)
Compression Therapy Market Market Summary
The global compression therapy market size was estimated at USD 4.25 billion in 2024 and is projected to reach USD 5.34 billion by 2030, growing at a CAGR of 3.8% from 2025 to 2030. The market growth can be attributed to the increasing prevalence of vein disorders such as leg ulcers, Deep Vein Thrombosis (DVT), lymphedema, varicose veins, and blood clots.
Key Market Trends & Insights
- North America compression therapy market dominated the global market with a revenue share of 42.43% in 2024. The compression therapy market in Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period. Based on technology, the static compression therapy segment led the market with the largest revenue share of 69.08% in 2024. Based on end-use, the hospitals segment led the market with the largest revenue share in 2024. Based on distribution channel, the institutional sales led the market with the largest revenue share in 2024.
Market Size & Forecast
- 2024 Market Size: USD 4.25 Billion
- 2030 Projected Market Size: USD 5.34 Billion
- CAGR (2025-2030): 3.8%
Regional Insights
U.S. Compression Therapy Market Trends The compression therapy market in U.S. is expected to dominate the market over the forecast period. The U.S. population's aging demographic is leading to an increased prevalence of conditions such as Peripheral Artery Disease (PAD), a common indication for compression therapy. According to a research article published by Vascular Disease Management in April 2023, the U.S. population's PAD prevalence has increased from 11.3 million in 1995 to an estimated 26 million in 2020. This increase can be attributed to an aging population, and the number is projected to reach 23.8 million by 2030 due to the aging population. Furthermore, growing awareness about the benefits of compression therapy in managing various conditions, including PAD, Deep Vein Thrombosis (DVT), and post-thrombotic syndrome, is driven by research, clinical trials, and patient testimonials. Europe Compression Therapy Market Trends The compression therapy market in Europe is expected to grow at a significant CAGR over the forecast period. This growth can be attributed to the rising geriatric population and market advancements. Moreover, the region's advanced healthcare infrastructure, coupled with a focus on minimally invasive medical interventions, fosters the adoption of compression therapy products. The UK compression therapy market is expected to grow at a moderate CAGR over the forecast period.The aging population in the UK, prone to venous ulcers, foot ulcers, and edema, necessitates the use of compression therapy to prevent recurrence & manage symptoms. The high incidence of DVT, affecting 1 to 2 out of every 1,000 people annually, which increases with age, underscores the importance of compression therapy in DVT management. Compression therapy, including compression hosiery, bandaging, or other devices, plays a critical role in DVT management. The compression therapy market in France is expected to grow at the fastest CAGR over the forecast period, owing to the rising geriatric population and increasing prevalence of CVDs in this region. Germany compression therapy market is anticipated to witness a steady CAGR over the forecast period. The increasing demand for better healthcare facilities and equipment, the aging population, and the growing prevalence of chronic diseases are driving the demand for compression therapy. Asia Pacific Compression Therapy Market Trends The compression therapy market in Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period. The market in the Asia Pacific region has been experiencing significant growth, driven by several key factors, such as the increasing prevalence of chronic diseases, including venous disorders, lymphedema, and DVT, among the region's population. According to an article published in 2023, “Epidemiology and prevention of venous thromboembolism,” in Asia, the rates of VTE are lower than in Europe and the U.S. For instance, the incidence of VTE in South Korea was estimated to be 0.2 per 1,000 person-years. Moreover, the rising geriatric population, coupled with the growing awareness about the benefits of compression therapy in managing such conditions, has further fueled market expansion. Technological advancements, such as innovative compression garment designs & materials, have enhanced patient comfort and compliance, boosting market demand. China compression therapy market is expected to grow at the fastest CAGR over the forecast period,owing to the growing geriatric population and the increasing prevalence of chronic disorders, such as diabetes & cardiovascular conditions, which have heightened the demand for compression therapy products. The compression therapy market in India is propelled by factors such as the country’s escalating burden of chronic diseases, such as diabetes, obesity, and venous disorders. These diseases necessitate effective management of related symptoms such as poor circulation and swelling, thereby driving demand for compression therapy solutions. For instance, as per the Indian Council of Medical Research, India Diabetes (ICMR INDIAB) study published in 2023, the prevalence of diabetes is 10.1 crores. Japan compression therapy market is expected to grow at the fastest CAGR over the forecast period, owing to several key factors, such as the rising geriatric population, technological advancements, and product innovations. Middle East & Africa Compression Therapy Market Trends The compression therapy market in Middle East and Africa is expected to witness a significant CAGR during the forecast period, due to increasing investments in healthcare infrastructure, and rising prevalence of chronic diseases. Advancements in the healthcare system are expected to boost the development of the medical device industry in this region. Growing health insurance penetration, increasing privatization, and rising regional disease burden are factors expected to drive regional market growth. Saudi Arabia compression therapy market is expected to grow at the fastest CAGR over the forecast period. In Saudi Arabia, the prevalence of CVI is significantly high, with 45.6% of the adult population affected, especially in the Western region. This high prevalence, higher than in Western countries, is linked to lifestyle factors and risk factors such as age, family history, prolonged standing occupation, and use of hormonal therapy. This scenario presents a competitive market for CVI treatment products and services, emphasizing the need for innovative solutions & targeted interventions to address the prevalent risk factors. The compression therapy market in Kuwait is expected to grow at a significant CAGR over the forecast period, due to escalating prevalence of chronic conditions and rising healthcare expenditure.
Company Insights
Essity Aktiebolag (publ). Cardinal Health Julius Zorn GmbH Hartmann AG Medi GmbH & Co. SIGVARIS BSN Medical GmbH ArjoHuntleigh 3M Health Care Spectrum Healthcare Bio Compression Systems, Inc. Stryker Gottfried Medical Tactile Medical